US stocks rallied Tuesday as Wall Street awaited the results of a closely contested presidential race. The Dow rose over 425 ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Q3 2024 Earnings Call Transcript November 4, 2024 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $-0.06. Operator: Good afternoon, and welcome to Castle ...

The consensus rating for Gilead Sciences is Neutral, based on 16 analyst ratings. With an average one-year price target of $84.25, there's a potential 6.22% downside.